مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| چکلیست CONSORT: استانداردهای گزارشدهی کارآزماییهای بالینی تصادفی× | ابزار کاکرین برای ارزیابی خطر سوگیری 2.0 در کارآزماییهای بالینی تصادفیشده× | |
|---|---|---|
| حوزه | روششناسی پژوهش | روششناسی پژوهش |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 2010 (original 1996) | 2019 |
| پدیدآور≠ | Schulz et al. (CONSORT Group) | Jonathan Sterne, Julian Higgins (Cochrane Collaboration) |
| نوع≠ | Trial author reporting checklist | Clinician-rated / Research team assessment |
| منبع بنیادین≠ | Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. The Lancet, 375(9721), 1657–1668. DOI ↗ | Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. DOI ↗ |
| نامهای دیگر | CONSORT, CONSORT 2010 | RoB 2.0, RoB 2 |
| مرتبط | 4 | 4 |
| خلاصه≠ | The CONSORT (Consolidated Standards of Reporting Trials) Statement is a 25-item evidence-based checklist and flow diagram developed to standardize reporting of parallel-group randomized controlled trials. First published in 1996 and updated in 2010 (CONSORT 2010), it is endorsed by over 600 journals including The Lancet, JAMA, and BMJ, and is mandatory or strongly recommended for RCT manuscript submission across clinical research. | RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias. |
| ScholarGateمجموعهداده ↗ |
|
|